- Drug Pipelines
- July 2024
- 80 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- August 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- May 2024
- 137 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- June 2024
- 200 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Report
- June 2024
- 200 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Report
- June 2024
- 200 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Clinical Trials
- April 2024
- 85 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Drug Pipelines
- April 2024
- 50 Pages
Global
From €1426EUR$1,500USD£1,198GBP
- Clinical Trials
- April 2024
- 100 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Clinical Trials
- July 2024
- 458 Pages
Global
From €3280EUR$3,450USD£2,755GBP
- Report
- February 2025
- 100 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- June 2024
- 200 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Report
- April 2024
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- September 2022
- 30 Pages
Global
From €3090EUR$3,250USD£2,596GBP
- Report
- September 2022
- 30 Pages
Global
From €3090EUR$3,250USD£2,596GBP
- Report
- January 2022
- 200 Pages
Global
From €9031EUR$9,500USD£7,587GBP
- Report
- January 2022
- 60 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Drug Pipelines
- January 2022
- 100 Pages
Global
From €5419EUR$5,700USD£4,552GBP
- Report
- January 2022
- 60 Pages
Global
From €3755EUR$3,950USD£3,155GBP

The Urticaria Drug market is a subset of the Immune Disorders Drugs market, which focuses on the treatment of allergic reactions and other immune-related conditions. Urticaria, also known as hives, is a common skin condition characterized by itchy, raised welts on the skin. Urticaria drugs are used to reduce the symptoms of the condition, such as itching, swelling, and redness. These drugs can be administered orally, topically, or intravenously, depending on the severity of the condition. Commonly used urticaria drugs include antihistamines, corticosteroids, and leukotriene receptor antagonists.
Some companies in the Urticaria Drug market include GlaxoSmithKline, Sanofi, Novartis, Pfizer, and Merck. Show Less Read more